Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · capsules

Epic Peptides Lab · USA

Document number: PL-SDS-155
Revision: 1.0 · 2026-10-03

SR-9011

capsules

1Identification

Product Identifier

SR-9011

Document Number

PL-SDS-155

Catalogue Items Covered

Id
8666
Name
SR-9011 5mg Capsules
Sku
PL-SR9011-5MG-CAP

Recommended Use

Laboratory research use by trained personnel.

Restrictions On Use

Not for human or veterinary use.

Supplier / Distributor

Epic Peptides Lab, USA

Telephone

+1 (787) 468-5291

info@epicpeptideslab.com

2Hazard(s) identification

Classification: Not classified as hazardous under OSHA HCS 2012 (29 CFR 1910.1200) or UN GHS, on the basis of the supplier safety data sheets consulted.
Label Elements: No data available.
Signal Word: No data available.
Other Hazards: No data available.

3Composition / information on ingredients

Description

Hard gelatin capsules containing the active substance blended with microcrystalline cellulose, packed in a sealed bottle.

Composition

Name
SR-9011
Full
SR9011, REV-ERB agonist
Cas
1379686-29-9
Formula
C23H31ClN4O3S
Conc
1.2% w/w of capsule contents (nominal)
Qty
5 mg per capsule
Hazards
- Acute toxicity, oral — Category 4 — H302
- Skin corrosion/irritation — Category 2 — H315
- Serious eye damage/eye irritation — Category 2A — H319
Name
Microcrystalline cellulose
Full
Microcrystalline cellulose (capsule filler)
Cas
9004-34-6
Formula
(C6H10O5)n
Conc
balance of capsule contents
Name
Gelatin
Full
Gelatin (capsule shell)
Cas
9000-70-8
Conc
capsule shell

4First-aid measures

First Aid Measures

Inhalation: Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.

Most Important Symptoms And Effects

No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

Likely Routes Of Exposure

Ingestion; inhalation of dust and skin/eye contact if capsules are opened.

5Fire-fighting measures

Fire Fighting Information: Combustible organic solid; capsule contents may form combustible dust if dispersed in bulk.

6Accidental release measures

Spill And Clean Up Procedures: Collect intact capsules. Dampen any spilled powder with water, wipe up with absorbent material and place in a sealed container for disposal.

7Handling and storage

Safe Handling: Do not open or crush capsules unless required for an experiment; if capsule contents are handled as a powder, avoid generating dust and weigh inside a ventilated enclosure. Wash hands after handling.
Safe Storage: Store at room temperature (15–25 °C) in the tightly closed original container, dry and protected from light.
Storage Temperature: 15–25 °C, dry, protected from light
Incompatible Materials: Strong oxidizing agents (Cayman); strong acids/alkalis, strong oxidising/reducing agents (ChemicalBook)

8Exposure controls / personal protection

Occupational Exposure Limits: Microcrystalline cellulose: OSHA PEL 15 mg/m³ (total dust), 5 mg/m³ (respirable fraction); ACGIH TLV 10 mg/m³ (as cellulose).

No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE: No data available.

9Physical and chemical properties

Physical State

Solid

Appearance

Hard gelatin capsules containing a white to off-white powder

Properties

Odor: Characteristic (Cayman)
Ph: Not applicable (solid)
Melting: Undetermined
Boiling: Undetermined (Cayman); 642.8 +/- 50.0 °C (predicted, ChemicalBook)
Flash: Not applicable (non-flammable solid); combustible organic material
Vapour: Negligible (solid)
Density: No data available (bulk density of lyophilized cake is low)
Solubility: DMF 30 mg/mL; DMSO 30 mg/mL; ethanol 14 mg/mL (Cayman); slightly soluble in chloroform and methanol (ChemicalBook); poorly water-soluble
Logp: No data available
Decomp: No data available; peptides decompose above about 200 °C
Other: C23H31ClN4O3S, MW 479.0; density 1.254 g/cm3 (predicted, ChemicalBook); CAS 1379686-29-9

10Stability and reactivity

Stability And Reactivity

Reactivity: Stable under recommended storage conditions; no decomposition if used according to specifications (Cayman)
Incompatible: Strong oxidizing agents (Cayman); strong acids/alkalis, strong oxidising/reducing agents (ChemicalBook)
Decomposition: Under fire conditions may decompose and emit toxic fumes (ChemicalBook): carbon oxides, nitrogen oxides, sulfur oxides, hydrogen chloride
Conditions To Avoid: Heat, light, moisture, incompatible materials

Conditions To Avoid

Heat, light, moisture, incompatible materials

Incompatible Materials

No data available.

11Toxicological information

Toxicological Information: Acute toxicity, oral
No LD50 available; ChemicalBook SDS classifies Acute Tox. 4 oral (H302) without data; Cayman does not classify for acute toxicity

Acute toxicity, dermal
No data available

Acute toxicity, inhalation
No data available

Skin corrosion/irritation
Irritant to skin and mucous membranes - Skin Irrit. 2, H315 (Cayman)

Serious eye damage/irritation
Irritating effect - Eye Irrit. 2A, H319 (Cayman)

Respiratory or skin sensitisation
No data available

Germ cell mutagenicity
No data available

Carcinogenicity
Not listed by IARC, NTP, OSHA

Reproductive toxicity
No data available

STOT, single exposure
No data available

STOT, repeated exposure
No data available

Aspiration hazard
No data available
Routes Of Exposure: Ingestion; inhalation of dust and skin/eye contact if capsules are opened.
Symptoms: No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information: No ecotoxicity data. Cayman self-assesses water hazard class 1 (slightly hazardous for water); ChemicalBook: no data for toxicity, persistence, bioaccumulation, mobility.

13Disposal considerations

Disposal Guidance: No data available.

14Transport information

Transport Classification

Note: Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information

Tsca: Not listed (Cayman)
Carcinogen Listings: Not listed (IARC, NTP, OSHA, EPA, California Prop 65)
Dea: Not a controlled substance; not an approved drug (never entered human trials)
Other: Not dangerous goods for transport (ChemicalBook). WADA remark: prohibited at all times under S4.4 metabolic modulators (REV-ERB agonists, e.g. SR9009 - SR9011 is the close analogue and falls under the class).

Carcinogen Listings

No data available.

16Other information

Revision: October 3, 2026
Sources Consulted: Cayman Chemical

ChemicalBook

Spectrum Chemical

Sigachi Industries

Parchem

Fisher Scientific / Acros Organics

Electron Microscopy Sciences
Confidence: high
Additional Information: REV-ERB agonist; WADA Prohibited List class S4.4.

Back to SDS list